What makes our strategy meetings unique?
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Meet Our Past Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Dr. Tao GuoSVP, Head of WuXi Chemistry – IDSU WuXi AppTec
Andreas SchoopsHead of Medicinal Chemistry WuXi AppTec
Greg MakaraCEO ChemPass
Onur AtasoyluDirector, Head of Computational Chemistry Incyte
Govinda BhisettiVice President and Head of Computational Chemistry Cellarity
Matt BursavichVice President, Head of Chemical Sciences Morphic Therapeutic
Heather CarlsonVice President Chemical Data Sciences Odyssey Therapeutics
Richard HeidebrechtVice President and R&D Glycologix
Jason ImbriglioVice President, Head of Discovery Chemistry Roivant Discovery
Kevin KreutterVP Drug Discovery Empress Therapeutics
Elaine KruegerSenior Director Early Research, Head of Lead Generation Chemistry Relay Therapeutics
Stephanos LoannidisEVP Drug Discovery Exo Therapeutics
Andrew McRinerVice President, Head of Drug Discovery Auron Therapeutics
Ed OlhavaSenior Vice President, Preclinical Development IFM Therapeutics
Lewis PenningtonSenior Director. Head of Platform Chemistry Kymera Therapeutics
Nisha PerezSenior Director, Head of DMPK ROME Therapeutics
Jennifer PetterFounder & CSO Arrakis Therapeutics
Daniel J. PriceExecutive Director, Head of Computational Chemistry Nimbus Therapeutics
Dominic ReynoldsSenior Vice President, Head of Drug Discovery Remix Therapeutics
Atli ThorarensenVice President, Head of Chemistry Cellarity
Aimee UseraVice President Chemistry Odyssey Therapeutics
Who Should Attend the Event?
Chief Executive Officers
Executive Vice Presidents
Hit and Lead Chemist
Small/Large Molecules Chemist
Drug Discovery or Drug Development
See Which Topics Are Discussed at the Strategy Meeting
Target Mediated Drug Disposition (TMDD): Addressing Pharmacokinetic And PK/PD Interactions To Establish Potency Of Compound Prior To Clinical Phase
Reasons To Attend the Strategy Meeting
Discussions on the advancements in targeted protein degradation andrnpushing past its boundaries.
Leveraging Artificial Intelligence and Machine Learning in accelerating therndevelopment of new drugs
Discuss approaches to further understand the interactions of undruggablerntargets and different Protein Degraders such as PROTACs, Molecular Glues,rnetc
Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more
Press play to hear what your colleagues had to say…
Here To Help
Want to know more? Interested in sponsoring the event? Need help registering your team?rnrnJust get in touch and a member of the team will be happy to help.